These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 6204749

  • 1. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
    Ruiter DJ, Bergman W, Welvaart K, Scheffer E, van Vloten WA, Russo C, Ferrone S.
    Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
    [Abstract] [Full Text] [Related]

  • 2. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T, Ishihara T, Campoli M, Ferrone S.
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [Abstract] [Full Text] [Related]

  • 3. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M.
    Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
    Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC.
    J Immunol; 1982 Dec 15; 129(6):2808-15. PubMed ID: 6183345
    [Abstract] [Full Text] [Related]

  • 5. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D, Alexander MA, Elder DE, Herlyn MF.
    J Immunol; 1987 Jul 01; 139(1):305-12. PubMed ID: 3108402
    [Abstract] [Full Text] [Related]

  • 6. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.
    Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S, Ferrone S.
    Cancer Res; 1993 Jul 15; 53(14):3349-54. PubMed ID: 7686817
    [Abstract] [Full Text] [Related]

  • 7. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D, Fossati G, Mazzocchi A, Delia D, Ferrone S, Parmiani G.
    Cancer Res; 1986 Jan 15; 46(1):433-9. PubMed ID: 3079589
    [Abstract] [Full Text] [Related]

  • 8. MHC antigens in human melanomas.
    Ruiter DJ, Mattijssen V, Broecker EB, Ferrone S.
    Semin Cancer Biol; 1991 Feb 15; 2(1):35-45. PubMed ID: 1912517
    [Abstract] [Full Text] [Related]

  • 9. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ.
    Cancer Res; 1985 Sep 15; 45(9):4401-11. PubMed ID: 4028024
    [Abstract] [Full Text] [Related]

  • 10. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.
    van Duinen SG, Ruiter DJ, Broecker EB, van der Velde EA, Sorg C, Welvaart K, Ferrone S.
    Cancer Res; 1988 Feb 15; 48(4):1019-25. PubMed ID: 3338074
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
    López-Nevot MA, Garcia E, Romero C, Oliva MR, Serrano S, Garrido F.
    Exp Clin Immunogenet; 1988 Feb 15; 5(4):203-12. PubMed ID: 3078572
    [Abstract] [Full Text] [Related]

  • 12. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S, Bröcker EB, de Leij L, Terbrack D, Visscher T, Ter Haar A, Macher E, Thé TH, Sorg C.
    Clin Exp Immunol; 1983 Jan 15; 51(1):77-82. PubMed ID: 6219841
    [Abstract] [Full Text] [Related]

  • 13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR, El-Zammar O.
    Am J Dermatopathol; 2008 Apr 15; 30(2):117-22. PubMed ID: 18360113
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.
    Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E.
    Am J Pathol; 1995 Dec 15; 147(6):1615-25. PubMed ID: 7495287
    [Abstract] [Full Text] [Related]

  • 15. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
    D'Alessandro G, Zardawi I, Grace J, McCarthy WH, Hersey P.
    Pathology; 1987 Oct 15; 19(4):339-46. PubMed ID: 3328139
    [Abstract] [Full Text] [Related]

  • 16. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldman M.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [Abstract] [Full Text] [Related]

  • 17. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases.
    van Duinen SG, Ruitter DJ, Ferrone S.
    J Pathol; 1986 Aug 01; 149(4):339-48. PubMed ID: 3531448
    [Abstract] [Full Text] [Related]

  • 18. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M, Guerry D, Koprowski H.
    J Immunol; 1985 Jun 01; 134(6):4226-30. PubMed ID: 2985706
    [Abstract] [Full Text] [Related]

  • 19. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
    Kornstein MJ, Brooks JS, Elder DE.
    Cancer Res; 1983 Jun 01; 43(6):2749-53. PubMed ID: 6342758
    [Abstract] [Full Text] [Related]

  • 20. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
    Ericsson C, Seregard S, Bartolazzi A, Levitskaya E, Ferrone S, Kiessling R, Larsson O.
    Invest Ophthalmol Vis Sci; 2001 Sep 01; 42(10):2153-6. PubMed ID: 11527924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.